Role of conformational alteration in the epidermal growth factor receptor (EGFR) function

被引:76
作者
Bishayee, S [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA
关键词
conformation-specific antibody; EGF receptor; N-linked glycosylation; phosphorylation sites; receptor tyrosine kinases; type III truncated EGFR;
D O I
10.1016/S0006-2952(00)00425-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This mini-review addresses the effect of glycosylation and phosphorylation on the conformational alterations of the epidermal growth factor receptor (EGFR). Based on studies with full-length and truncated EGFRs, we propose a model to suggest that receptor-receptor self-association, which occurs in the truncated receptor and depends on core glycosylation, is prevented in intact receptor by a certain extracellular domain and that the function of the ligand is to remove the negative constraint. We also propose, based on works with a conformation-specific antibody directed to an unphosphorylated peptide, that the interactions among negatively charged phosphotyrosine residues in the receptor molecule result in bringing two epitopes separated by a long stretch of amino acids close to each other to form an antibody-binding site. The implications of these posttranslational modifications on receptor functions are also discussed in this article. BIOCHEM PHARMACOL 60;8:1217-1223, 2000. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1217 / 1223
页数:7
相关论文
共 24 条
[1]   Disulfide bond structure of human epidermal growth factor receptor [J].
Abe, Y ;
Odaka, M ;
Inagaki, F ;
Lax, I ;
Schlessinger, J ;
Kohda, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11150-11157
[2]   ANTISERUM RAISED AGAINST A SYNTHETIC PHOSPHOTYROSINE-CONTAINING PEPTIDE SELECTIVELY RECOGNIZES P185(NEU/ERBB-2) AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
BANGALORE, L ;
TANNER, AJ ;
LAUDANO, AP ;
STERN, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11637-11641
[3]  
Biscardi JS, 1999, ADV CANCER RES, V76, P61
[4]   Conformational analysis of the phosphorylated epidermal growth factor receptor [J].
Bishayee, A ;
Beguinot, L ;
Bishayee, S .
BIOSCIENCE REPORTS, 1999, 19 (05) :397-402
[5]   Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor C-terminal tail [J].
Bishayee, A ;
Beguinot, L ;
Bishayee, S .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (03) :525-536
[6]  
Bishayee S, 1999, PRACT APPROACH SER, V215, P95
[7]   CHARACTERIZATION OF A NOVEL ANTI-PEPTIDE ANTIBODY THAT RECOGNIZES A SPECIFIC CONFORMATION OF THE PLATELET-DERIVED GROWTH-FACTOR RECEPTOR [J].
BISHAYEE, S ;
MAJUMDAR, S ;
SCHER, CD ;
KHAN, S .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (09) :3696-3702
[8]   Immunodetection of the Ligand-Activated Receptor for Epidermal Growth Factor [J].
Campos-Gonzalez, Roberto ;
Glenney, John R., Jr. .
GROWTH FACTORS, 1991, 4 (04) :305-316
[9]  
CASE RD, 1994, J BIOL CHEM, V269, P10467
[10]   SYNTHETIC PHOSPHOPEPTIDE IMMUNOGENS YIELD ACTIVATION-SPECIFIC ANTIBODIES TO THE C-ERBB-2 RECEPTOR [J].
EPSTEIN, RJ ;
DRUKER, BJ ;
ROBERTS, TM ;
STILES, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10435-10439